As of August 28, 2026, Lakefront Biotherapeutics NV (GLPG) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Lakefront Biotherapeutics NV has a market capitalization of $1.86B, 65.90M shares outstanding, 92 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for GLPG.
Market Data
Market Cap$1.86B
Shares Outstanding65.90M
Float44.52M
Cash$3.48B
Debt$7.50M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 2.6% shares (2026Q1 vs prior)
92 institutional holders · 32.56M shares
#1
GILEAD SCIENCES, INC.
16.71M shares
#2
TANG CAPITAL MANAGEMENT LLC
3.79M shares
#3
Madison Avenue Partners, LP
2.47M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track GLPG Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLPG — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for GLPG
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.